中国生物科技服务控股有限公司（股票代码：08037）于2026年5月5日公布截至2026年4月30日的股份变动月报表。公告显示，公司本月底注册股本仍为2,000,000,000股，每股面值0.1港元，总额200,000,000港元，与上月末保持一致。
报告期内，公司已发行股份（不包括库存股）仍为975,731,150股，未发生任何新增发行、购回或注销，也无库藏股变动。公司披露了先前已发行的可换股债券信息，但当月并未因此产生任何新增股份的发行或转让。
公司同时确认其符合香港联交所相关上市规则的最低公众持股量要求。截至4月30日，总股本保持稳定。公司进一步声明，所有已进行或计划进行的证券发行动作均符合适用的法律法规及上市规则。本次公告由执行董事刘小林签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.